| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/03/2010 | CA2743986A1 A nonapeptide with anti-tumour activity |
| 06/03/2010 | CA2743824A1 Implantable ocular drug delivery device and methods |
| 06/03/2010 | CA2741764A1 Synthetic mimetics of host defense and uses thereof |
| 06/03/2010 | CA2740793A1 Method for the treatment of hemophilia |
| 06/02/2010 | EP2192407A2 Method of detecting cellular immunity and application thereof to drugs |
| 06/02/2010 | EP2192192A1 Kinase and phosphatase assays |
| 06/02/2010 | EP2192187A2 Compositions and methods for si-RNA inhibition of angiogenesis |
| 06/02/2010 | EP2192179A1 Cdh3 peptide and medicinal agent comprising the same |
| 06/02/2010 | EP2192129A1 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 06/02/2010 | EP2192127A1 Haemophilus influenzae type IV Pili |
| 06/02/2010 | EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i> |
| 06/02/2010 | EP2191847A1 Method for preparing compositions comprising a protein, water and glycerol |
| 06/02/2010 | EP2191845A1 Immunology significant herpes simplex virus antigens and methods for using same |
| 06/02/2010 | EP2191839A2 Immunogenic LHRH compositions and methods relating thereto |
| 06/02/2010 | EP2191838A1 Erythropoetin for the stimulation of endothelial precursor cells |
| 06/02/2010 | EP2191837A1 Blood sugar-modulating polypeptides |
| 06/02/2010 | EP2191823A1 Methods for improving bioavailability of a renin inhibitor |
| 06/02/2010 | EP2190978A2 A method for identifying, expanding, and removing adult stem cells and cancer stem cells |
| 06/02/2010 | EP2190874A1 Insulin-like growth factor fusion proteins |
| 06/02/2010 | EP2190873A1 Truncated glp-1 derivatives and their therapeutical use |
| 06/02/2010 | EP2190872A1 Glucagon-like peptide-1 derivatives and their pharmaceutical use |
| 06/02/2010 | EP2190871A1 Improved derivatives of amylin |
| 06/02/2010 | EP2190870A1 Cell marker of melanocyte cell lineage and uses thereof |
| 06/02/2010 | EP2190869A1 Method for prolonging longevity |
| 06/02/2010 | EP2190868A2 Methods of inhibiting calcineurin with apoe analogs |
| 06/02/2010 | EP2190858A2 Urea-containing peptides as inhibitors of viral replication |
| 06/02/2010 | EP2190856A2 Polypeptides with modified amino acids |
| 06/02/2010 | EP2190467A1 Materials and methods for treating or preventing organophosphate exposure associated damage |
| 06/02/2010 | EP2190465A2 Use of a peptide as a therapeutic agent |
| 06/02/2010 | EP2190464A2 Use of leptin(22-56) as a therapeutic agent |
| 06/02/2010 | EP2190463A2 Use of thymopentin as a therapeutic agent |
| 06/02/2010 | EP2190461A2 Use of parathyroid hormone (1-34) as anti-hiv agent |
| 06/02/2010 | EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 06/02/2010 | EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
| 06/02/2010 | EP2190455A1 Agents with angiogenic and wound healing activity |
| 06/02/2010 | EP2190454A2 Delivery systems for solubilising water-insoluble pharmaceutical active ingredients |
| 06/02/2010 | EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/02/2010 | EP2190452A2 Use of a peptide as a therapeutic agent |
| 06/02/2010 | EP2190451A1 Treatment of atherosclerosis |
| 06/02/2010 | EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 06/02/2010 | EP2190448A2 Methods and uses thereof of prosaposin |
| 06/02/2010 | EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent |
| 06/02/2010 | EP2190429A1 A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| 06/02/2010 | EP2190304A1 Nutritional formulation with high energy content |
| 06/02/2010 | EP1924593B9 Hcv ns3 protease inhibitors |
| 06/02/2010 | EP1817057B1 Sodium stibogluconate and il-2 for treating cancer |
| 06/02/2010 | EP1699915B1 Use of erythropoietin for liver tissue regeneration |
| 06/02/2010 | EP1539812B1 Osteoinductive biomaterials |
| 06/02/2010 | EP1481000B1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 06/02/2010 | EP1438299B1 Bifunctional chelating agent for actinium |
| 06/02/2010 | EP1301146B1 Artificial vascular grafts and methods of producing and using same |
| 06/02/2010 | EP1066050B2 Application of hsp70 proteins |
| 06/02/2010 | DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links |
| 06/02/2010 | CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage |
| 06/02/2010 | CN1800385B Hybrid expression of neisserial proteins |
| 06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
| 06/02/2010 | CN1539499B Liquid composition comprising interferon for local use |
| 06/02/2010 | CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101720331A Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin |
| 06/02/2010 | CN101720220A Compositions for nasal delivery |
| 06/02/2010 | CN101717804A Method for preparing medical III type collagen |
| 06/02/2010 | CN101717761A Application of lumbrukinase in treating carotid atherosclerosis |
| 06/02/2010 | CN101717449A Recombinant TRAIL-Fc fusion protein as well as preparation and application thereof |
| 06/02/2010 | CN101717442A Polyethylene glycol recombination DesB30 human insulin, preparation method and application thereof |
| 06/02/2010 | CN101717441A Venin-sourced demulcent CTXn, and purification method and applications thereof |
| 06/02/2010 | CN101717439A Venin-derived cytotoxin CTXn for drug rehabilitation and purification method and application thereof |
| 06/02/2010 | CN101716345A Antigen presenting cell targeted nano particles and preparation method thereof |
| 06/02/2010 | CN101716337A Liquid medicine for treating dermatophytosis and tinea pedis |
| 06/02/2010 | CN101716336A Yikang capsule and production process thereof |
| 06/02/2010 | CN101716335A Stable recombinant human interferon ointment |
| 06/02/2010 | CN101716334A Biological medicament for treating ischemic cardiovascular disease and skin ulcer |
| 06/02/2010 | CN101716333A Preparation method of pupa glycoprotein immunoregulation preparation |
| 06/02/2010 | CN101716332A Use of phycocyanin for preventing and treating diabetes mellitus |
| 06/02/2010 | CN101716331A Method for embedding protein biological macromolecules by using amylopectin-p-nitrocinnamic acid graft in situ |
| 06/02/2010 | CN101716214A Medical composition containing dandelion extract as well as novel application and preparation method thereof |
| 06/02/2010 | CN101716161A New thymosin chitosan microsphere type oral medicinal preparation and preparation method thereof |
| 06/02/2010 | CN101716156A Ubenimex dispersive tablet composition |
| 06/02/2010 | CN101716146A Vancomycin slow release microsphere with magnetic filed compliance and preparation method thereof |
| 06/02/2010 | CN101366946B Starch based segmented intestine targeting specific adhesion material, preparation and application thereof |
| 06/02/2010 | CN101270154B Cyclo-pentapeptide with antineoplastic activity |
| 06/02/2010 | CN101264331B New purpose of Chinese medicine almond |
| 06/02/2010 | CN101214263B Method for preparing freeze-dried powder containing bacillus natto and nattokinase |
| 06/02/2010 | CN101143902B Anti-HER2 single-chain antibody-cefuroxime sodium enhanced fusion protein HER2(Fv-LDM) |
| 06/02/2010 | CN101104847B Vipera berus snake poison blood coagulation X factor activating enzyme and its extracting method and application |
| 06/01/2010 | US7728127 Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/01/2010 | US7728116 Method of preparing an osteogenic protein fraction |
| 06/01/2010 | US7728111 Anti-p55 TNF receptor antibody |
| 06/01/2010 | US7728105 Peptides impairing PBX dependent gene regulation |
| 06/01/2010 | US7728104 Process for preparing glycopeptide phosphonate derivatives |
| 06/01/2010 | US7728000 compounds which intercalate between DNA base pairs, resulting in an interruption of transcription, replication and/or topoisomerase activity; antiproliferative and antitumor agents |
| 06/01/2010 | US7727970 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus |
| 06/01/2010 | US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
| 06/01/2010 | US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism |
| 06/01/2010 | US7727963 ligands or agonists of the kappa opioid receptors, that exhibit low cytochrome P450 inhibition and low penetration into the brain, useful in the prophylaxis or treatment of pain and inflammation |
| 06/01/2010 | US7727962 Powder comprising new compositions of oligosaccharides and methods for their preparation |
| 06/01/2010 | US7727961 Antioxidant constituents |
| 06/01/2010 | US7727960 Neutropenia; treating autoimmune diseases, acute inflammatory diseases, trauma, local inflammations, shock and burn |
| 06/01/2010 | US7727959 Use of substances with oxytocin activity against climacteric disorders |
| 06/01/2010 | US7727958 Pharmaceutical formulation |